• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用瘤周和瘤内超声放射组学预测乳腺癌亚型新辅助化疗的腋窝反应

Predicting axillary response to neoadjuvant chemotherapy using peritumoral and intratumoral ultrasound radiomics in breast cancer subtypes.

作者信息

Yao Jiejie, Jia Xiaohong, Zhou Wei, Zhu Ying, Chen Xiaosong, Zhan Weiwei, Zhou Jianqiao

机构信息

Department of Ultrasound, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

iScience. 2024 Aug 13;27(9):110716. doi: 10.1016/j.isci.2024.110716. eCollection 2024 Sep 20.

DOI:10.1016/j.isci.2024.110716
PMID:39280600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11399604/
Abstract

To explore machine learning (ML)-based breast tumor peritumoral (P) and intratumoral ultrasound radiomics signatures (IURS) for predicting axillary response to neoadjuvant chemotherapy (NAC) in patients with breast cancer (BC) with node-positive. A total of 435 patients were divided into hormone receptor (HR)+/human epidermal growth factor receptor (HER)2-, HER2+, and triple-negative (TN) subtypes. ML classifiers including random forest (RF), support vector machine (SVM), and linear discriminant analysis (LDA) were applied to construct PURS, IURS, and the combined P-IURS radiomics models. SVM of the TN subtype obtained the most favorable performance with an AUC of 0.917 (95%CI: 0.859, 0.960) in PURS models, RF of the HER2+ subtype yielded the highest efficacy in IURS models [AUC = 0.935 (95%CI: 0.843, 0.976)]. The RF-based combined P-IURS model of the HER2+ subtype improved the efficacy to a maximum AUC of 0.952 (95%CI: 0.868, 0.994). ML-based US radiomics can be a promising biomarker to predict axillary response.

摘要

为探索基于机器学习(ML)的乳腺癌(BC)伴淋巴结阳性患者的瘤周(P)和瘤内超声放射组学特征(IURS),以预测新辅助化疗(NAC)后的腋窝反应。共435例患者被分为激素受体(HR)+/人表皮生长因子受体(HER)2-、HER2+和三阴性(TN)亚型。应用包括随机森林(RF)、支持向量机(SVM)和线性判别分析(LDA)在内的ML分类器构建PURS、IURS以及联合P-IURS放射组学模型。TN亚型的SVM在PURS模型中表现最佳,AUC为0.917(95%CI:0.859,0.960);HER2+亚型的RF在IURS模型中疗效最高[AUC = 0.935(95%CI:0.843,0.976)]。HER2+亚型基于RF的联合P-IURS模型将疗效提高到最大AUC为0.952(95%CI:0.868,0.994)。基于ML的超声放射组学可能是预测腋窝反应的一种有前景的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/e71a0dd5134d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/77042899c30b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/5684dea0bc47/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/6ddca215a64b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/dec21fa4e9a8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/fdaabf1b3cf3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/40be77ee27d1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/e71a0dd5134d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/77042899c30b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/5684dea0bc47/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/6ddca215a64b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/dec21fa4e9a8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/fdaabf1b3cf3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/40be77ee27d1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec52/11399604/e71a0dd5134d/gr6.jpg

相似文献

1
Predicting axillary response to neoadjuvant chemotherapy using peritumoral and intratumoral ultrasound radiomics in breast cancer subtypes.利用瘤周和瘤内超声放射组学预测乳腺癌亚型新辅助化疗的腋窝反应
iScience. 2024 Aug 13;27(9):110716. doi: 10.1016/j.isci.2024.110716. eCollection 2024 Sep 20.
2
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.基于乳腺动态对比增强磁共振成像的瘤内和瘤周影像组学对新辅助化疗病理完全缓解的治疗前预测
Breast Cancer Res. 2017 May 18;19(1):57. doi: 10.1186/s13058-017-0846-1.
3
Machine Learning Model for Predicting Axillary Lymph Node Metastasis in Clinically Node Positive Breast Cancer Based on Peritumoral Ultrasound Radiomics and SHAP Feature Analysis.基于瘤周超声影像组学和SHAP特征分析的临床淋巴结阳性乳腺癌腋窝淋巴结转移预测机器学习模型
J Ultrasound Med. 2024 Sep;43(9):1611-1625. doi: 10.1002/jum.16483. Epub 2024 May 29.
4
Machine Learning-Based Breast Tumor Ultrasound Radiomics for Pre-operative Prediction of Axillary Sentinel Lymph Node Metastasis Burden in Early-Stage Invasive Breast Cancer.基于机器学习的乳腺肿瘤超声影像组学在早期浸润性乳腺癌术前预测前哨淋巴结转移负荷中的应用
Ultrasound Med Biol. 2024 Feb;50(2):229-236. doi: 10.1016/j.ultrasmedbio.2023.10.004. Epub 2023 Nov 10.
5
Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.基于对比增强光谱乳腺摄影术的瘤内和瘤周放射组学用于乳腺癌新辅助化疗效果的术前预测
Eur Radiol. 2022 May;32(5):3207-3219. doi: 10.1007/s00330-021-08414-7. Epub 2022 Jan 23.
6
Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.基于早期动态对比增强磁共振成像的瘤内及瘤周放射组学模型用于浸润性导管癌分子亚型的术前预测:一项多任务机器学习研究
Front Oncol. 2022 Jun 24;12:905551. doi: 10.3389/fonc.2022.905551. eCollection 2022.
7
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.HER2(ERBB2)阳性乳腺癌术前靶向治疗的肿瘤生物学和病理反应与肿瘤周围放射组学的相关性。
JAMA Netw Open. 2019 Apr 5;2(4):e192561. doi: 10.1001/jamanetworkopen.2019.2561.
8
Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.基于肿瘤内和肿瘤周围 DCE-MRI 放射组学列线图的乳腺癌腋窝淋巴结转移术前预测。
Contrast Media Mol Imaging. 2022 Aug 18;2022:6729473. doi: 10.1155/2022/6729473. eCollection 2022.
9
Deep Learning vs. Radiomics for Predicting Axillary Lymph Node Metastasis of Breast Cancer Using Ultrasound Images: Don't Forget the Peritumoral Region.使用超声图像预测乳腺癌腋窝淋巴结转移的深度学习与影像组学:不要忽视瘤周区域
Front Oncol. 2020 Jan 31;10:53. doi: 10.3389/fonc.2020.00053. eCollection 2020.
10
Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study.基于纵向超声的人工智能模型预测乳腺癌新辅助化疗腋窝淋巴结反应:一项多中心研究。
Eur Radiol. 2024 Nov;34(11):7080-7089. doi: 10.1007/s00330-024-10786-5. Epub 2024 May 10.

引用本文的文献

1
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer.用于预测三阴性乳腺癌中三级淋巴结构和治疗反应的机器学习模型
NPJ Precis Oncol. 2025 Jul 1;9(1):216. doi: 10.1038/s41698-025-01012-6.
2
Habitat radiomics predicts occult lymph node metastasis and uncovers immune microenvironment of head and neck cancer.影像组学预测头颈部癌隐匿性淋巴结转移并揭示其免疫微环境
J Transl Med. 2025 May 1;23(1):498. doi: 10.1186/s12967-025-06474-7.
3
Decoding breast cancer imaging trends: the role of AI and radiomics through bibliometric insights.

本文引用的文献

1
Machine Learning-Based Breast Tumor Ultrasound Radiomics for Pre-operative Prediction of Axillary Sentinel Lymph Node Metastasis Burden in Early-Stage Invasive Breast Cancer.基于机器学习的乳腺肿瘤超声影像组学在早期浸润性乳腺癌术前预测前哨淋巴结转移负荷中的应用
Ultrasound Med Biol. 2024 Feb;50(2):229-236. doi: 10.1016/j.ultrasmedbio.2023.10.004. Epub 2023 Nov 10.
2
Discordant Breast and Axillary Pathologic Response to Neoadjuvant Chemotherapy.新辅助化疗后乳房和腋窝病理反应不一致。
Ann Surg Oncol. 2023 Dec;30(13):8302-8307. doi: 10.1245/s10434-023-14082-2. Epub 2023 Aug 22.
3
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023.
解读乳腺癌成像趋势:通过文献计量学见解看人工智能和放射组学的作用
Breast Cancer Res. 2025 Feb 25;27(1):29. doi: 10.1186/s13058-025-01983-1.
4
Machine learning for predicting neoadjuvant chemotherapy effectiveness using ultrasound radiomics features and routine clinical data of patients with breast cancer.利用超声影像组学特征和乳腺癌患者的常规临床数据进行机器学习以预测新辅助化疗疗效
Front Oncol. 2025 Jan 14;14:1485681. doi: 10.3389/fonc.2024.1485681. eCollection 2024.
5
Prediction of lymphovascular invasion in invasive breast cancer based on clinical-MRI radiomics features.基于临床 MRI 放射组学特征预测浸润性乳腺癌的淋巴管血管侵犯。
BMC Med Imaging. 2024 Oct 16;24(1):277. doi: 10.1186/s12880-024-01456-5.
临床医学中的人工智能与机器学习,2023年。
N Engl J Med. 2023 Mar 30;388(13):1201-1208. doi: 10.1056/NEJMra2302038.
4
Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.超声深度学习影像组学用于全面预测乳腺癌患者新辅助化疗后的肿瘤及腋窝淋巴结状态:一项多中心研究
Cancer. 2023 Feb 1;129(3):356-366. doi: 10.1002/cncr.34540. Epub 2022 Nov 19.
5
A Synthetic Minority Oversampling Technique Based on Gaussian Mixture Model Filtering for Imbalanced Data Classification.一种基于高斯混合模型滤波的合成少数类过采样技术用于不平衡数据分类
IEEE Trans Neural Netw Learn Syst. 2024 Mar;35(3):3740-3753. doi: 10.1109/TNNLS.2022.3197156. Epub 2024 Feb 29.
6
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.《NCCN 肿瘤学临床实践指南:乳腺癌》第 3.2022 版
J Natl Compr Canc Netw. 2022 Jun;20(6):691-722. doi: 10.6004/jnccn.2022.0030.
7
Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment.影像组学通过反映肿瘤细胞异质性和肿瘤微环境来预测局部晚期乳腺癌患者的预后。
Breast Cancer Res. 2022 Mar 15;24(1):20. doi: 10.1186/s13058-022-01516-0.
8
Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.基于对比增强光谱乳腺摄影术的瘤内和瘤周放射组学用于乳腺癌新辅助化疗效果的术前预测
Eur Radiol. 2022 May;32(5):3207-3219. doi: 10.1007/s00330-021-08414-7. Epub 2022 Jan 23.
9
A Clinical-Radiomics Model for Predicting Axillary Pathologic Complete Response in Breast Cancer With Axillary Lymph Node Metastases.一种用于预测伴有腋窝淋巴结转移的乳腺癌腋窝病理完全缓解的临床影像组学模型。
Front Oncol. 2021 Dec 21;11:786346. doi: 10.3389/fonc.2021.786346. eCollection 2021.
10
Interpretation of radiomics features-A pictorial review.影像组学特征解读——图文综述
Comput Methods Programs Biomed. 2022 Mar;215:106609. doi: 10.1016/j.cmpb.2021.106609. Epub 2021 Dec 27.